Supply of medicines under Amgros’s 2027 procurement

Summary

Amgros I/S is procuring framework agreements in 16 medicine supply lots for hospital pharmacies serving regional hospitals in Denmark, with possible resale to the Faroe Islands and Greenland. The lots cover, among other products, ondansetron, coagulation factor VII, amphotericin, rezafungin, rifampicin, sirolimus, tretinoin, tetracaine, acetylsalicylic acid, nimorazole, acetylcysteine, acetazolamide, fluorescein with lidocaine, fomepizole and Patent Blue in various dosage forms. The estimated total value is DKK 40.1 million. The ordinary purchasing period runs from 1 April 2027 to 31 March 2028, with an option to extend the framework agreement by up to 12 months.